Jordan is a regional leader for the provision of medical services. In 2024, 9.6 percent of Jordan’s GDP consumption was devoted to healthcare services, which is high compared to other countries. There are 121 hospitals, 71 of which are private, 15 are military hospitals and two are University hospitals. The Ministry of Health and Royal Medical Services play the main role in the public sector.  Jordan has more than 16,000 hospital beds, with 51 percent of the beds in public hospitals.  Jordanians increasingly suffer from asthma, cancer, diabetes, obesity, strokes, vascular disease, osteoarthritis, rheumatoid arthritis, and osteoporosis. Opportunities exist for technologies that prevent or treat these conditions, as well as supplying equipment for new and existing medical facilities. The country is facing heavy demands on its resources due to a growing population and being the host of the world’s second-highest number of refugees per capita. 

The country is also a regional leader in medical tourism, with nationals from neighboring and Gulf Cooperation Council (GCC) countries seeking treatment in Jordan. Patients from abroad are attracted by the shorter wait times, relaxed visa restrictions for medical tourists, and availability of quality treatment at an affordable cost for treatments ranging from cardiac diseases and oncology to infertility and cosmetic surgery. In 2024, Jordan received 225,000 patients accounting for a significant percentage of the country’s tourism revenue and is expected to reach 290,000 in 2025, surpassing pre-COVID levels. Medical tourists frequently visit Jordan for procedures such as joint replacements, rhinoplasty, coronary artery bypass grafting, cataract surgeries, and IVF treatments, among others. In 2025, the Jordanian government announced an agreement to provide free cancer treatment to 4.1 million children and senior citizens through the King Hussein Cancer Center (KHCC), starting January 1, 2026.

KHCC provides specialized cancer care for patients of all ages from Jordan and the Middle East. It is accredited by the Joint Commission International (JCI) as a disease-specific cancer center, the first in the developing world and only the sixth worldwide to receive this distinction. Located in Amman, KHCC is one of the leading cancer hospitals in the region.

In 2019, the Ministry of Health prohibited the import of used and refurbished medical devices for all the health sectors.  Jordan requires U.S. Food and Drug Administration, CE marking, or Japanese certification for all imported medical devices.  

Leading Sub-sectors

Hospital projects and private clinic investments have created demand for medical equipment used in the following areas:

•    Cardiology and cardiovascular surgery
•    Laparoendoscopic surgery
•    Kidney transplantation
•    Ophthalmology
•    Neurosurgery
•    Equipment and supplies for plastic surgery
•    Oncology
•    Consumables for clinical laboratories (i.e. tubes/glasses)
•    Medical surgical sterilizers
•    Medical x-ray, alpha, beta, gamma ray equipment
•    Orthopedic & prosthetic appliances

Key opportunity areas for companies in the e-health and digital healthcare space include: 
•    E-health
•    Healthcare management systems
•    Software modules for specific fields and applications (radiology, imaging, etc.)
•    Integrated medical insurance solutions
•    Customer relations management
•    Medical devices and equipment
•    Mobile healthcare applications
•    Online medical content providers

Opportunities

In 2024, Jordan’s healthcare expenditures were valued around $4 billion, with spending distributed equally between the public and private sectors. Jordan is not a major manufacturer of medical devices. Domestic production primarily focuses on low-technology products, such as medical dressings, syringes, dental supplies, and optical products. However, these are not produced in sufficient quantities to meet the needs of the Jordanian market. Consequently, 75 percent of the total market is sourced through imports, with the U.S. being the leading supplier of medical devices to Jordan with competition from Europe and Turkey. U.S approximately takes a quarter of the total market suppliers are the main source of diagnostic imaging equipment, orthopedics and prosthetics, patient aids, and other medical devices.

A strong medical tourism sector as well as projects to renovate existing and establish new medical facilities are key drivers behind expenditures in the sector.  Additionally, Jordan has a significant number of refugees requiring medical services, and the country has an average of two percent annual population growth rate. With 70 percent of the population aged 35 and younger, this youthful demographic is expected to drive continued demand for healthcare services in the coming years.

The government is expanding its Hakeem Electronic Health Records Program, an e-health initiative which focuses on the storage, retrieval and updating of electronic patient health records managed by healthcare facilities and has started to include the private sector. As of 2024, the Hakeem Program has expanded to include 278 public and private health facilities.  Hakeem utilizes the VistA system for implementation, an enterprise-wide information system used throughout the U.S. Department of Veterans Affairs (VA) medical system. U.S. suppliers of e-health solutions will find opportunities to respond to procurement announcements.

The annual Arab Health Trade Exhibition takes place in Dubai and is certified by the U.S. Department of Commerce. Arab Health provides a valuable opportunity to engage with Jordanian buyers of medical technologies.

Procurement in Jordan’s healthcare sector is split between the public and private sectors, offering multiple entry points for U.S. businesses. In the public sector, the Ministry of Health (MoH), Royal Medical Services (RMS) oversee major healthcare projects, including digital health infrastructure and medical equipment procurement. The Government Procurement Department (GPD) manages centralized purchasing, particularly for pharmaceuticals and medical devices. While foreign companies are eligible to bid, partnering with a local distributor or agent is often essential to meet registration and compliance requirements, particularly with the Jordan Food and Drug Administration (JFDA)

In the private sector, Jordan boasts a fast-growing network of private hospitals, clinics, and labs—especially in Amman that mostly procures independently based on institutional needs. These entities often source medical equipment, software, and pharmaceutical products directly from international suppliers. Establishing relationships with private hospital procurement officers, attending trade events, or engaging through local agents can open commercial opportunities. With the continued expansion of medical tourism and digital health services in the private sector, demand for U.S. medical technologies and services is expected to grow.

Other examples of ongoing or upcoming hospital project opportunities: 
•    The Saudi Jordanian Investment Fund (SJIF), UCL Medical School and UCLA Health have partnered on a $400 million healthcare public-private partnership project in Amman. The healthcare project will consist of a university hospital with 330 beds, more than 70 outpatient clinics, an ambulatory care building, and a medical school with capacity for 600 students, with a projected annual student intake of 100 students.

•    The King Hussein Cancer Center (KHCC), which partners with top U.S. cancer hospitals, is building a standalone pediatric treatment center as part of its broader expansion (2023–2027). The facility will include outpatient clinics for children, around 140 beds, a gene therapy unit, a pediatric emergency department, and a pediatric palliative care unit. The KHCC also plans to construct a new 28,000 m² building for ambulatory care and research. It will include a nuclear medicine department using isotopes from a new cyclotron, a physiotherapy and rehabilitation unit for cancer patients, research labs, and chemotherapy treatment floors.

•    The Pandemic Readiness Enhancement Program is focusing on upgrading the country’s prevention, preparedness, and response (PPR) capabilities and minimizing the public health risks to its expanding population.  

•    The Government of Jordan and KBW Investments have signed two foreign investment agreements worth a combined JD 133 million (approximately USD 187 million) to advance Jordan’s healthcare infrastructure. The first agreement establishes a brand‑new, fully government‑operated public hospital in Madaba under a pioneering public–private partnership. The 13‑story facility will span 54,000 m² and initially offer around 260 beds, expandable to 360.  The hospital is expected to be completed by 2028. The second agreement, signed between the Jordan Armed Forces and Farah Jordan Smart Cities (49 percent owned by KBW), will launch a digital transformation project across Royal Medical Services (RMS) facilities modernizing inventory systems, minimizing waste, and improving management of medical supplies, equipment, labs, radiology units, and technical staffing

For additional information, please contact U.S Commercial Service - Jordan at office.amman@trade.gov